[1] Zheng Y,Li M,Wang H, et al.Japanese encephalitis and Japanese encephalitis virus in mainland China,Rev Med Virol,2012,22(5):301-322.
[2] Campbell G L, Hills S L, Fischer M,et al. Estimated global incidence of Japanese encephalitis: a systematic review,Bulletin of the World Health Organization, 2011,89(10):766-774.
[3] Erlanger T E, Weiss S, Keiser J, et al. Past, present, and future of Japanese encephalitis, Emerging Infectious Diseases,2009,15:1-7.
[4] Ghosh D,Basu A.Japanese encephalitis-a pathological and clinical perspective, PLoS Neglected Tropical Diseases,2009,3(9):e437.
[5] 王宇明,施光峰,宁琴,等.感染病学.人民卫生出版社,2010.8:164. Wang Y M, Shi G F, Ning Q,et al.Infection Internationa.Beijing:People's Medical Publishing House, 2010.8:164.
[6] Ghosh D, Basu A. Japanese encephalitis——a pathological and clinical perspective, PLoS Neglected Tropical Diseases,2009,3(9):e437.
[7] van den Hurk A F, Ritchie S A,Mackenzie J S. Ecology and geographical expansion of Japanese encephalitis virus, Annual Review of Entomology,2009,54:17-35.
[8] 谢荣辉,朱函坪,张晓锋,等.浙江省猪血清中乙脑病毒的分离鉴定及抗体的测定.中国人兽共患病学报,2010,26(12):1123-1125. Xie R H, Zhu H P, Zhang X F,et al.Isolation of Japanese encephalitis virus and detection of antibody against Japanese encephalitis virus in serum of swine from Zhejiang, Chinese Journal of Zoonoses,,2010,26(12):1123-1125.
[9] Misra U K, Kalita J. Overview:Japanese encephalitis. Progress in Neurobiology, 2010,91(2):108-200.
[10] Ohrr H,Tandan J B,Sohn Y M,et al.Effect of single dose of SAl4-14-2 vaccine l year after immunization in Nepalese children with Japanese encephalitis:a case-control study.Lancet,2005,366:1375-1378.
[11] Wu Chang Jer, Li Tsung Lin,Huang Hui Wen,et al.Development of an effective Japanese encephalitis virus-specific DNA vaccine.Microbes Infection,2006,8:2578-2586.
[12] 黄莺,邵炜,贾丽丽,等.日本脑炎病毒(JEV)复制子表达载体的构建及其鉴定.病毒学报,2007,23(1):33-38. Huang Y, Shao W, Jia L L, et al.Construction and application of subgenomic replicon vectors of Japanese encephalitis virus.Chinese Journal of Virology, 2007,23(1):33-38.
[13] 汤德元,郭万柱.日本脑炎病毒及其疫苗的研究.中国兽医学报,2005,25:217-221. Tang D Y, Guo W Z. The development of Japanese encephalitis vaccine and vaccine research .Chinese Journal of Veterinary Science, 2005,25:217-221.
[14] Pugachev K V,Schwaiger J,Brown N,et al.Construction and biological characterization of artificial recombinants between a wild type flavivirus(Kunjin) and a live chimeric flavivirus vaccine(ChimeriVax-JE) .Vaccine,2007,25:666l-6671.
[15] Jones T.A chimeric live attenuated vaccine against Japanese encephalitis.Expert Rev Vaccines,2004,3:243-248.
[16] Chimeri Vax-JE Acambis plc. Acambis JE vaccine meets and exceeds primary endpoint in pivotal phase 3 efficacy trial.2007-03-01.
[17] Halstead S B, Thomas S J. New Japanese encephalitis vaccines: alternatives to production in mouse brain .Expert Rev Vaccine,2011,10(3):355-364.
[18] Wu S C, Yu C H, Lin C W, et al.The domain Ⅲ fragment of Japanese encephalitis virus envelope protein:mouse immunogenicity and liposome adjuvanticity.Vaccine, 2003,21(19/20):2516-2522.
[19] 杨杜鹃,李铭华,付士红,等.我国2009年新分离乙脑病毒全基因组序列特征研究.病毒学报,2011,27(6):571-579. Yang D J, Li M H, Fu S H, et al.Molecular characteristics of the full-length genomes of Japanese encephalitis virus strains newly isolated in 2009, China .Chinese Journal of Virology, 2011,27(6):571-579.
[20] 张括生,尚莉丽.近百年来流行性乙型脑炎流行病学特征及中医药防治乙脑策略进展.中医药临床杂志,2011,23(10):926-929. Zhang K S,Shang L L.Progress in epidemiological characteristics of epidemic encephalitis B and TCM prevention and treatment strategy of Japanese encephalitis in recent hundred years. Clinical Journal of Traditional Chinese Medicine, 2011,23(10):926-929.
[21] Fei-fei G,Jian W,Feng X,et al.Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine .Vaccine,2008,26(44):5590-5594.
[22] Dewasthaly S S, Bhonde G S,Shankarraman V,et al.Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice .Protein Pept Lett,2007,14(6):543-551.
[23] Wang L,Coppel R L.Oral vaccine delivery:can it protect against non-mucosal pathogens .Expert Rev Vaccines,2008,7(6):729-738. |